Fresenius Medical Care AG & Co. KGaA’s (FMS) “Hold” Rating Reaffirmed at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft restated their hold rating on shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) in a report issued on Tuesday morning, The Fly reports.

FMS has been the subject of several other reports. Truist Securities dropped their target price on Fresenius Medical Care AG & Co. KGaA from $44.00 to $40.00 and set a hold rating for the company in a research report on Wednesday, October 13th. Societe Generale reissued a hold rating on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Wednesday, August 4th. Truist lowered their price objective on Fresenius Medical Care AG & Co. KGaA from $44.00 to $40.00 and set a hold rating for the company in a research report on Wednesday, October 13th. TheStreet cut Fresenius Medical Care AG & Co. KGaA from a b- rating to a c+ rating in a research note on Friday, September 3rd. Finally, Barclays restated an equal weight rating on shares of Fresenius Medical Care AG & Co. KGaA in a research note on Thursday, October 21st. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and five have given a buy rating to the company. According to data from MarketBeat, Fresenius Medical Care AG & Co. KGaA presently has an average rating of Hold and an average target price of $40.00.

NYSE FMS opened at $34.25 on Tuesday. Fresenius Medical Care AG & Co. KGaA has a 52 week low of $33.84 and a 52 week high of $44.13. The company has a quick ratio of 0.78, a current ratio of 1.05 and a debt-to-equity ratio of 0.51. The business’s fifty day simple moving average is $37.34 and its 200-day simple moving average is $39.17. The firm has a market cap of $20.07 billion, a PE ratio of 16.87, a P/E/G ratio of 7.32 and a beta of 1.28.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last issued its quarterly earnings data on Friday, July 30th. The company reported $0.46 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.51 by ($0.05). The company had revenue of $5.20 billion during the quarter, compared to analysts’ expectations of $5.33 billion. Fresenius Medical Care AG & Co. KGaA had a net margin of 5.74% and a return on equity of 9.47%. Research analysts expect that Fresenius Medical Care AG & Co. KGaA will post 2.07 EPS for the current year.

Several institutional investors have recently added to or reduced their stakes in FMS. Cambiar Investors LLC purchased a new position in shares of Fresenius Medical Care AG & Co. KGaA in the 1st quarter worth about $57,173,000. Citigroup Inc. raised its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 138.5% in the 2nd quarter. Citigroup Inc. now owns 673,369 shares of the company’s stock worth $27,992,000 after purchasing an additional 391,064 shares during the period. BlackRock Inc. raised its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 201,714.1% in the 1st quarter. BlackRock Inc. now owns 171,542 shares of the company’s stock worth $6,327,000 after purchasing an additional 171,457 shares during the period. Goldman Sachs Group Inc. raised its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 33.7% in the 2nd quarter. Goldman Sachs Group Inc. now owns 523,718 shares of the company’s stock worth $21,771,000 after purchasing an additional 132,026 shares during the period. Finally, 1832 Asset Management L.P. grew its stake in shares of Fresenius Medical Care AG & Co. KGaA by 33.7% in the second quarter. 1832 Asset Management L.P. now owns 397,000 shares of the company’s stock valued at $16,381,000 after buying an additional 100,000 shares in the last quarter. Institutional investors own 3.49% of the company’s stock.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA engages in the provision of products and services for patients with chronic kidney failure. It also develop and manufacture a variety of health care products, which includes dialysis and non-dialysis products. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Further Reading: How to Trade Using Analysts Ratings

The Fly logo

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.